# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 516 results.
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced Sarcoma
Status: Recruiting
Last Changed: Sep 25, 2019
First Received: Aug 28, 2019
Disease(s): Sarcoma
Intervention(s): Apatinib monotherapy
Locations: Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma
Status: Available
Last Changed: Jan 14, 2020
First Received: Jan 13, 2020
Disease(s): Epithelioid Sarcoma
Intervention(s): Tazemetostat
Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
Status: Recruiting
Last Changed: May 20, 2019
First Received: Mar 22, 2019
Disease(s): Sarcoma
Intervention(s): Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC], Nivolumab IV Soln 100 MG/10ML, Trabectedin 0.25 MG/1 VIAL Intravenous Powder for Solution
Locations: Sarcoma Oncology Center, Santa Monica, California, United States
Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma
Status: Not yet recruiting
Last Changed: Oct 11, 2019
First Received: Oct 11, 2019
Disease(s): Undifferentiated Pleomorphic Sarcoma
Intervention(s): ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
Locations: University of California, San Francisco, San Francisco, California, United States
A Single-arm, Open, Phase II Study of Chidamide Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Status: Recruiting
Last Changed: Dec 27, 2019
First Received: Jul 19, 2019
Disease(s): Sarcoma
Intervention(s): chidamide and toripalimab
Locations: Sun Yat-Sen Univerisity, Guangzhou, Guangdong, China
Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Aug 08, 2019
First Received: May 02, 2018
Disease(s): Soft Tissue Sarcoma
Intervention(s): Patients starting a treatment with Doxorubicin and Ifosfamide
Locations: Institut Bergonie, Bordeaux, France
Institut Regional Du Cancer de Montpellier (Icm), Montpellier, France
Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse, France
A Study of Durvalumab in Combination With Doxorubicin and Olaratumab for Advanced Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Jan 14, 2020
First Received: Jan 14, 2019
Disease(s): Sarcoma
Intervention(s): Durvalumab+olaratumab+doxorubicin cobination
Locations: Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
Status: Recruiting
Last Changed: Jul 11, 2019
First Received: Jun 17, 2013
Disease(s): Sarcoma
Intervention(s): Docetaxel, Gemcitabine, Vorinostat, Pegfilgrastim
Locations: Sarcoma Oncology Center, Santa Monica, California, United States
Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
APX005M and Doxorubicin in Advanced Sarcoma
Status: Recruiting
Last Changed: Apr 05, 2019
First Received: Oct 25, 2018
Disease(s): Soft Tissue Sarcoma
Intervention(s): Doxorubicin, APX005M
Locations: Columbia University Medical Center, New York, New York, United States
Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Oct 15, 2019
First Received: Oct 15, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Apatinib Mesylate, Pirarubicin, Ifosfamide, Apatinib Mesylate, Pirarubicin, Ifosfamide
Locations: Tianjin Medical University Cancer Hospital & Institute, Tianjin, Tianjin, China